Synthesis of 2beta-substituted-14-epi-previtamin D3 and testing of its genomic activity

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):20-4. doi: 10.1016/j.jsbmb.2010.02.035. Epub 2010 Mar 7.

Abstract

2beta-substituted analogs of 14-epi-previtamin D(3) were synthesized for the first time by the thermal isomerization of the corresponding 14-epi-vitamin D3 that were available using coupling reaction between the A-ring phosphine oxide derived from a chiral epoxide and CD-ring cis-hydrindanone. The VDR binding affinity and transactivation activity of osteocalcin promoter in HOS cells were evaluated, and the new analogs were found to be less active, 0.01-0.18% of VDR binding affinity compared with the natural hormone and EC50 1.0-9.1 nM for transactivation activity, than 14-epi-previtamin D3 with 0.5% (VDR) and EC50 0.46 nM, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Chemistry, Pharmaceutical / methods
  • Cholecalciferol / analogs & derivatives*
  • Cholecalciferol / chemical synthesis*
  • Cholecalciferol / chemistry*
  • Cholecalciferol / pharmacology
  • Drug Design
  • Epoxy Compounds / chemistry
  • Humans
  • Models, Biological
  • Models, Chemical
  • Osteocalcin / genetics
  • Phosphines / chemistry
  • Promoter Regions, Genetic
  • Receptors, Calcitriol / metabolism
  • Stereoisomerism
  • Transcriptional Activation

Substances

  • Epoxy Compounds
  • Phosphines
  • Receptors, Calcitriol
  • Osteocalcin
  • Cholecalciferol
  • previtamin D(3)